Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Type 2 Diabetes Clinical Trials

111 recruiting trials for Type 2 Diabetes. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
111
Total Trials
111
Recruiting Now
8
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGPhase 3NCT07083154

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

The LIGHT-COG study is a 76-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial. A total of 420 type 2 diabetes patients with early...

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolEnrolling: 4208 locations
RECRUITINGNCT06338215

Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality

The goal of this clinical trial is to test two advices on alcohol drinking in more than 10.000 Spanish adult drinkers (men of 50 or more years and women of 55 or more years). The...

Sponsor: Clinica Universidad de Navarra, Universidad de NavarraEnrolling: 100001 location
RECRUITINGNCT06694012

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

The aim of this study is to investigate the relationship between body fat distribution measured by CT scan and related risk factors with the risk of incident metabolic and...

Sponsor: Osaka Metropolitan UniversityEnrolling: 20001 location
RECRUITINGPhase 1 / Phase 2NCT06143566

Polypill for Prevention of Cardiomyopathy

This study will investigate the utility of a polypill-based strategy for patients with type 2 diabetes mellitus and high risk of heart failure (HF), as assessed via the WATCH-DM...

Sponsor: University of Texas Southwestern Medical CenterEnrolling: 2001 location
RECRUITINGNCT06152588

Restricted Eating Time in the Treatment of Type 2 Diabetes

The overall aim of the present study is to investigate the effectiveness of implementing a 1-year time-restricted eating (TRE)-based intervention on glycaemic control, body weight...

Sponsor: Steno Diabetes Center CopenhagenEnrolling: 1601 location
RECRUITINGNCT07171281

Precise Eating Time to Improve Glycemic Control and Cardiometabolic Health in Prediabetes and Diabetes

The objective of this study is to investigate the impact of hypocaloric time-restricted eating (TRE) at different day times (early versus late TRE) on glucose metabolism and other...

Sponsor: German Institute of Human NutritionEnrolling: 301 location
RECRUITINGNCT05633706

Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis

The SIMBA Capsule is a small, single-use, ingestible capsule that allows for the non-invasive sampling of small bowel contents using purely mechanical means. The study will...

Sponsor: Nimble Science Ltd.Enrolling: 3001 location
RECRUITINGNCT06899191

Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED

The goal of this clinical trial is to improve the processes of Type 2 Diabetes (T2D) care coordination and treatment in the emergency department (ED) by utilizing clinical...

Sponsor: Rutgers, The State University of New JerseyEnrolling: 2001 location
RECRUITINGNCT07011147

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

The goal of this randomized controlled trial is to compare the efficacy and safety of the iLet Bionic Pancreas (BP) System in adults with insulin-treated diabetes (type 1 diabetes...

Sponsor: University of Colorado, DenverEnrolling: 2402 locations
RECRUITINGPhase 1NCT07349381

A Food-Effect Study of CX11 in Healthy Participants

This study is to evaluate the food effect (FE) on the PK of 200 mg CX11 in healthy participants

Sponsor: Vincentage Pharma Co., LtdEnrolling: 321 location
RECRUITINGPhase 1NCT05822544

Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes

The phase 1 portion of the study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TLC-6740 after single- and...

Sponsor: OrsoBio, IncEnrolling: 5644 locations
RECRUITINGNCT07350694

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and...

This project aims to adapt, implement, and evaluate PLA based intervention in Rural Kabul, Afghanistan for TIIDM prevention and control.

Sponsor: HealthNet Transcultural Psychosocial OrganizationEnrolling: 2501 location
RECRUITINGPhase 3NCT05569772

Semaglutide for the Treatment of Glucose Intolerance in Women with Prior Gestational Diabetes

Gestational diabetes (GDM) is an important contributor to the increasing prevalence of type 2 diabetes (T2DM). Women with glucose intolerance in early postpartum are a...

Sponsor: Universitaire Ziekenhuizen KU LeuvenEnrolling: 25213 locations
RECRUITINGNCT06841796

The YMCA Healthy Lifestyle Program for Prediabetes

The goal of this 26 week randomized controlled clinical trial is to learn if using a real time continuous glucose monitor (CGM) in a healthy lifestyle program for adults with...

Sponsor: Young Men's Christian Association of the Blue Water AreaEnrolling: 841 location
RECRUITINGNCT05799222

Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population

This study is being done to better understand whether meal replacements can be an effective tool for weight loss and treatment of elevated blood sugars in people with...

Sponsor: Massachusetts General HospitalEnrolling: 201 location
RECRUITINGNCT07431359

Evaluation of Dietary Knowledge and the Habit of Using the Mediterranean Diet in Patients With Diabetes

The main aim of this study is to evaluate nutritional knowledge and adherence to the Mediterranean diet through the administration of questionnaires in patients with type 2...

Sponsor: Casa di Cura Dott. PederzoliEnrolling: 5001 location
RECRUITINGEarly Phase 1NCT06609356

Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes

This study aims to understand the heart and blood sugar health benefits of using an adjunctive therapy to lower high insulin levels in people with type 1 diabetes. The...

Sponsor: Vanderbilt University Medical CenterEnrolling: 271 location
RECRUITINGNCT04621396

The Next Generation Longitudinal Birth Cohort Diabetes Study

The overall aim of this project is to understand the independent roles of maternal factors, intrauterine exposures, genetic factors, and postnatal environment on the development...

Sponsor: University of ManitobaEnrolling: 6001 location
RECRUITINGNCT07309094

Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD

Chronic kidney disease (CKD) is the progressive damage to kidney function, associated with an increased risk of cardiovascular diseases, such as stroke or myocardial infarct,...

Sponsor: Cardenal Herrera UniversityEnrolling: 2501 location
RECRUITINGNCT06185296

The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy

The trial is an open-label, randomized controlled trial. Patients with T2D on insulin therapy will be randomized to an intelligent telemonitoring group (intervention), a...

Sponsor: Aalborg University HospitalEnrolling: 511 location
RECRUITINGNCT06864546

A Participatory Approach to Support Glucose Tolerance Tracking in Real-Life of Patients With Type 2 Diabetes

Recent studies show that lifestyle interventions, such as exercise, healthy diet, and education, can help prevent type 2 diabetes in high-risk individuals, and even reverse the...

Sponsor: Enea ParimbelliEnrolling: 201 location
RECRUITINGPhase 1NCT07275788

A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)

REGEND003, which consists of human kidney progenitor cells, demonstrates promising potential in repairing kidney injury. The purpose of this study is to assess the saftey and...

Sponsor: Regend TherapeuticsEnrolling: 151 location
RECRUITINGNCT06591286

Effects of Real-time Continuous Glucose Monitoring System on Hospital-to-home Transitional Blood Glucose Control

Glucose monitoring is an important part of self-management for patients with diabetes. The results of glucose monitoring not only help to assess the degree of glucose metabolism...

Sponsor: Shanghai 6th People's HospitalEnrolling: 1501 location
RECRUITINGNCT07297342

A Prospective Randomnised Controlled Trial Comparing Overall Patient Compliance in a Bariatric Surgical Pathway Using...

The aim of this study is to assess the impact of a newly intensified digital platform following bariatric surgery. This will be measured using several questionnaires. The...

Sponsor: Sint Dimpna Ziekenhuis GeelEnrolling: 2001 location
RECRUITINGNCT05015283

Efficacy and Safety of One-anastomosis Versus Roux-en-Y Gastric Bypass for Type 2 Diabetes Remission

Diabetes mellitus (T2DM) is the most common complication of obesity patients. According to previous literature reports, weight loss and metabolic surgery are powerful means to...

Sponsor: Beijing Friendship HospitalEnrolling: 2481 location
RECRUITINGPhase 2NCT06661538

Implementing Food Referrals for Equity and Sustained Health

Food insecurity (FI) disproportionately affects those who have been historically marginalized and significantly contributes to poor health outcomes. In children, FI is associated...

Sponsor: University of California, San DiegoEnrolling: 6002 locations
RECRUITINGNCT07386340

Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash...

A prospective, multicenter evaluation of performance and safety of the Eversense Gemini System with flash glucose measurement feature. The purpose of this clinical investigation...

Sponsor: Senseonics, Inc.Enrolling: 801 location
RECRUITINGNCT07079189

Effect of the Digital Livsstilsverktyget in Conjunction With a Large Language Model on Glycemic Control in Patients...

The overall aim of the study is to observe the change of long-term metabolic control in patients with type 2 diabetes who have access to a digital intervention tool as compared...

Sponsor: Region SkaneEnrolling: 3001 location
RECRUITINGNCT07256613

Non-surgical Periodontal Therapy and Kidney Outcomes in Type 2 Diabetes Mellitus

Brief Summary (Lay Description) This research study is being conducted to understand whether treating gum disease (periodontitis) can help improve kidney health in patients who...

Sponsor: Dow University of Health SciencesEnrolling: 461 location
RECRUITINGPhase 1NCT06606327

Diazoxide Suppression Test P&F Study

The goal of this study is to learn about how the hormone insulin controls blood sugar. The main question it aims to answer is about how much insulin the body actually needs to...

Sponsor: Columbia UniversityEnrolling: 101 location
RECRUITINGNCT06599047

Regional Adipose Tissue Characteristics in Type II Diabetes

Fat tissue in different parts of the body has different characteristics. Several studies have associated abdominal fat to an increased risk for multiple metabolic diseases, such...

Sponsor: Concordia University, MontrealEnrolling: 1401 location
RECRUITINGPhase 4NCT05365425

Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

This is a randomized controlled study to assess the effect of choline fenofibrate compared with policosanol in Korean T2DM patients with asymptomatic atherosclerosis.

Sponsor: Seoul National University Bundang HospitalEnrolling: 561 location
RECRUITINGNCT05794789

"We Are an Active Family": Promoting Child Physical Activity Through Social Identity Formation in the Family System

The purpose of our study is to explore the effectiveness of physical activity (PA) identity formation in the family system as a promotor of long-term PA. The primary research...

Sponsor: University of VictoriaEnrolling: 1482 locations
RECRUITINGPhase 4NCT05366868

Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus

Study subjects will be randomly assigned to the three groups and receive the study drug for maximum of 156 weeks and undergo blood samplings and other diabetes mellitus-related...

Sponsor: National Center for Global Health and Medicine, JapanEnrolling: 5671 location
RECRUITINGPhase 2NCT07465224

A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus

The purpose of this study is to evaluate the effect of a single dose of ALN-4324 on whole-body insulin sensitivity in participants with T2DM

Sponsor: Alnylam PharmaceuticalsEnrolling: 401 location
RECRUITINGNCT07005362

Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D

The goal of this observational study is to evaluate the feasibility and acceptability of a 12-week intervention utilizing a Fitbit and artificial intelligence (AI)-delivered...

Sponsor: University of Colorado, DenverEnrolling: 361 location
RECRUITINGNCT06639425

Efficacy of Lactobacillus Paracasei LC19 on Type 2 Diabetes

This is a randomized, double-blind, placebo-controlled clinical trial. The objective of this trial is to determine whether Lactobacillus paracasei LC19 supplementation has a...

Sponsor: Beijing Chao Yang HospitalEnrolling: 601 location
RECRUITINGNCT06319560

Hydroxychloroquine in Type 2 Diabetes During Pregnancy

The goal of this clinical trial is to compare the use of hydroxychloroquine as an adjunct to the current treatment of pregnant women with Type 2 diabetes mellitus. The main...

Sponsor: National University of MalaysiaEnrolling: 561 location
RECRUITINGNCT05883072

Exploring the Effectiveness of AI Generative Models for Diabetic Patients

We plan to explore the usability of Generative AI-Chatbot for Diabetic Patient

Sponsor: Pakistan Council of Scientific and Industrial ResearchEnrolling: 3001 location
RECRUITINGNCT07293156

Impact of Pilates Exercises on Diabetic Erectile Dysfunction.

Erectile dysfunction (ED) has a prevalence of 52.5% in diabetic male patients, as described in a meta-analysis of 145 studies, including 88,577 men with type 1 and type 2...

Sponsor: Benha UniversityEnrolling: 602 locations
RECRUITINGPhase 3NCT06619301

RCT Glargine vs NPH for Treatment of DM in Pregnancy

We are asking you to take part in this research study because you are diagnosed with pregestational Type 2 Diabetes Mellitus or Gestational Diabetes Mellitus requiring insulin...

Sponsor: Loyola UniversityEnrolling: 1601 location
RECRUITINGPhase 3NCT06993792

A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2...

The purpose of this Master Protocol is to support two studies to see how well and how safely orforglipron works compared to placebo in participants who have obesity or overweight...

Sponsor: Eli Lilly and CompanyEnrolling: 120020 locations
RECRUITINGNCT06630182

Evaluation of the Impact of Psychological Profile on Diabetic Foot Wound Healing. Prospective, Monocentric Study

Foot wounds in patients with diabetes are one of the most frequent complications associated with diabetes. Despite the progress made in its management in recent years, the risk of...

Sponsor: Centre Hospitalier Universitaire DijonEnrolling: 3081 location
RECRUITINGNCT03761446

The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults

The goal of this study is to determine the impact of pre-diabetes and type 2 diabetes on muscle atrophy during a period of bed rest and recovery of muscle mass, strength, and...

Sponsor: AdventHealth Translational Research InstituteEnrolling: 501 location
RECRUITINGNCT05501483

Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes

People with newly diagnosed type 2 diabetes treated with metformin that have not reached their HbA1c target (42-64 mmol/mol) will be recruited to the study. If they fulfill the...

Sponsor: Karolinska InstitutetEnrolling: 601 location
RECRUITINGNCT06647888

Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia

This observational study is a non-interventional, multi-center, prospective observational study aimed at tracking the efficacy and safety of Envlo or Envlomet SR tablets for 24...

Sponsor: Daewoong Pharmaceutical Co. LTD.Enrolling: 120001 location
RECRUITINGNCT05888909

Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy

Diabetes nephropathy (DN) is one of the most serious microvascular complications of diabetes, and also an important cause of death and disability of diabetes patients. There is no...

Sponsor: Chinese PLA General HospitalEnrolling: 20001 location
RECRUITINGPhase 1NCT06945419

A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2...

The main purpose of this study is to evaluate the safety, tolerability of LY4086940 and how it is processed in the body. Participation in Part A of the study will last about 10...

Sponsor: Eli Lilly and CompanyEnrolling: 2165 locations
RECRUITINGNCT06571474

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

The goal of this study is to evaluate the role of transcription factor EB (TFEB) in adipose (fat) tissue macrophages (ATM) in regulating adipose tissue and systemic metabolic...

Sponsor: Bettina MittendorferEnrolling: 601 location
RECRUITINGPhase 3NCT07060456

Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal Insulin

The study is being conducted to evaluate the efficacy and safety of HRS9531 compared with placebo in participants with type 2 diabetes mellitus not adequately controlled with...

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.Enrolling: 3001 location

Showing 50 of 111 trials.Search all Type 2 Diabetes trials